Non-Hodgkin Lymphoma

Cancer Epidemiology and Prevention

Volumn , Issue , 2009, Pages

  Hartge, Patricia ^a   Wang, Sophia S ^a   Bracci, Paige M ^b   Devesa, Susan S ^a   Holly, Elizabeth A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer epidemiology; Cancer prevention; Cancer risk; Nhl; Non hodgkin lymphomas

Indexed keywords

EID: 77949475968     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195149616.003.0046     Document Type: Chapter

References (384)

1. Adami HO, Tsaih S, Lambe M, et al. 1997. Pregnancy and risk of non-Hodgkin's lymphoma: A prospective study. Int J Cancer 70:155-158.
2. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. 1995. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 310:1491-1495.
3. Adami J, Gabel H, Lindelof B, et al. 2003. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 89:1221-1227.
4. Adami J, Glimelius B, Cnattingius S, et al. 1996. Maternal and perinatal factors associated with non-Hodgkin's lymphoma among children. Int J Cancer 65:774-777.
5. Adami J, Gridley G, Nyren O, et al. 1999. Sunlight and non-Hodgkin's lymphoma: A population-based cohort study in Sweden. Int J Cancer 80:641-645.
6. Adami J, Nyren O, Bergstrom R, et al. 1998. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9:49-56.
7. Ahlbom IC, Cardis E, Green A, Linet M, Savitz D, Swerdlow A. 2001. Review of the epidemiologic literature on EMF and Health. Environ Health Perspect 109 Suppl 6:911-933.
8. Ahsan H, Neugut AI. 1996. High risk of Kaposi's sarcoma and central nervous system lymphoma in the same individuals: A finding related to acquired immunodeficiency syndrome. Int J Cancer 66:176-178.
9. Alexander FE, McKinney PA, Moncrieff KC, Cartwright RA. 1992. Residential proximity of children with leukaemia and non-Hodgkin's lymphoma in three areas of northern England. Br J Cancer 65:583-588.
10. Alizadeh AA, Eisen MB, Davis RE, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
11. Alpen B, Neubauer A, Dierlamm J, et al. 2000. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95:4014-4015.
12. Altekruse SF, Henley SJ, Thun MJ. 1999. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 10:617-625.
13. Archer VE, Wagoner JK, Lundin FE, Jr. 1973. Cancer mortality among uranium mill workers. J Occup Med 15:11-14.
14. Ascoli V, Lo CF, Torelli G, et al. 2002. Human herpesvirus 8-associated primary effusion lymphoma in HIV-patients: A clinicopidemiologic variant resembling classic Kaposi's sarcoma. Haematologica 87:339-343.
15. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. 2002. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428-1435.
16. Baecklund E, Sundstrom C, Ekbom A, et al. 2003. Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48:1543-1550.
17. Bartholomew C, Jack N, Edwards J, et al. 1998. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J Hum Virol 1:302-305.
18. Bates WD, Gray DW, Dada MA, et al. 2003. Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 56:439-446.
19. Bayerdorffer E, Neubauer A, Rudolph B, et al. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345:1591-1594.
20. Becker N, Berger J, Bolm-Audorff U. 2001. Asbestos exposure and malignant lymphomas-a review of the epidemiological literature. Int Arch Occup Environ Health 74:459-469.
21. Bener A, Denic S, Al Mazrouei M. 2001. Consanguinity and family history of cancer in children with leukemia and lymphomas. Cancer 92:1-6.
22. Bentham G. 1996. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 312:1128-1131.
23. Beral V, Inskip H, Fraser P, Booth M, Coleman D, Rose G. 1985. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J (Clin Res Ed) 291:440-447.
24. Beral V, Peterman T, Berkelman R, Jaffe H. 1991. AIDS-associated non-Hodgkin lymphoma. Lancet 337:805-809.
25. Bernstein L, Ross RK. 1992. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: Preliminary results from a case-control study in Los Angeles County. Cancer Res 52:5510s-5515s.
26. Berrington A, Darby SC, Weiss HA, Doll R. 2001. 100 years of observation on British radiologists: Mortality from cancer and other causes 1897-1997. Br J Radiol 74:507-519.
27. Besson C, Goubar A, Gabarre J, et al. 2001. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339-2344.
28. Biggar RJ. 2000. Epidemiology of malignancies in HIV/AIDS. In: Feigal EG, Levine AM, Biggar RJ, eds. AIDS-Related Cancers and Their Treatment. New York: M. Dekker, pp. 25-58.
29. Biggar RJ, Engels EA, Frisch M, Goedert JJ. 2001. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 26:371-376.
30. Blair A, Hartge P, Stewart PA, McAdams M, Lubin J. 1998. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: Extended follow up. Occup Environ Med 55:161-171.
31. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. 1992. Sjogren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore) 71:386-401.
32. Blomberg J, Moller T, Olsson H, Anderson H, Jonsson M. 1993. Cancer morbidity in blood recipients-results of a cohort study. Eur J Cancer 29A: 2101-2105.
33. Boffetta P, Andersen A, Lynge E, Barlow L, Pukkala E. 1994. Employment as hairdresser and risk of ovarian cancer and non-Hodgkin's lymphomas among women. J Occup Med 36:61-65.
34. Boice JD, Jr., Marano DE, Fryzek JP, Sadler CJ, McLaughlin JK. 1999. Mortality among aircraft manufacturing workers. Occup Environ Med 56:581-597.
35. Borisch B, Raphael M, Swerdlow SH, Jaffe E. 2001. Lymphoproliferative diseases associated with primary immune disorders. In: Jaffe E, Harris NL, Stein H, Variman J, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, pp. 257-259.
36. Boulanger E, Agbalika F, Maarek O, et al. 2001. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J 2:172-179.
37. Briggs NC, Levine RS, Bobo LD, Haliburton WP, Brann EA, Hennekens CH. 2002. Wine drinking and risk of non-Hodgkin's lymphoma among men in the United States: A population-based case-control study. Am J Epidemiol 156:454-462.
38. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. 1997. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176:572-579.
39. Brown LM. 2000. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 22:283-297.
40. Brown LM, Gibson R, Burmeister LF, Schuman LM, Everett GD, Blair A. 1992. Alcohol consumption and risk of leukemia, non-Hodgkin's lymphoma, and multiple myeloma. Leuk Res 16:979-984.
41. Burkitt D. 1958. A sarcoma involving the jaw in African children. Br J Radiol 1958:218-223.
42. Burnett C, Robinson C, Walker J. 1999. Cancer mortality in health and science technicians. Am J Ind Med 36:155-158.
43. Burns CJ, Beard KK, Cartmill JB. 2001. Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: An update. Occup Environ Med 58:24-30.
44. Cacoub P, Fabiani FL, Musset L, et al. 1994. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96:124-132.
45. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638.
46. Cantor KP, Blair A, Everett G, et al. 1988. Hair dye use and risk of leukemia and lymphoma. Am J Public Health 78:570-571.
47. Cantor KP, Strickland PT, Brock JW, et al. 2003. Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: betahexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environ Health Perspect 111:179-183.
48. Carbone A. 2003. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4:22-29.
49. Carbone A, Gloghini A, Capello D, Gaidano G. 2001. Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer 37:1270-1275.
50. Carbone M, Pass HI, Miele L, Bocchetta M. 2003. New developments about the association of SV40 with human mesothelioma. Oncogene 22:5173-5180.
51. Cardis E, Gilbert ES, Carpenter L, et al. 1995. Effects of low doses and low dose rates of external ionizing radiation: Cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117-132.
52. Carpenter L, Higgins C, Douglas A, Fraser P, Beral V, Smith P. 1994. Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946-1988. Radiat Res 138:224-238.
53. Carroll-Pankhurst C, Engels EA, Strickler HD, Goedert JJ, Wagner J, Mortimer EA, Jr. 2001. Thirty-five year mortality following receipt of. Br J Cancer 85:1295-1297.
54. Centers for Disease Control (CDC). 1982. Update on acquired immune deficiency syndrome (AIDS)-United States. MMWR Morb Mortal Wkly Rep 31:507-504.
55. Cerhan JR, Habermann TM, Vachon CM, et al. 2002a. Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: The lowa women's health study (United States). Cancer Causes Control 13:131-136.
56. Cerhan JR, Vachon CM, Habermann TM, et al. 2002b. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 11:1466-1471.
57. Cerhan JR, Wallace RB, Dick F, et al. 2001. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 10:361-368.
58. Cerhan JR, Wallace RB, Folsom AR, et al. 1997. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 89:314-318.
59. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191.
60. Cesarman E, Mesri EA. 1999. Virus-associated lymphomas. Curr Opin Oncol 11:322-332.
61. Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J. 2000. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: Biologic and clinical significance. Semin Hematol 37:396-411.
62. Chan JK. 2001. The new World Health Organization classification of lymphomas: The past, the present and the future. Hematol Oncol 19:129-150.
63. Chiu BC, Cerhan JR, Folsom AR, et al. 1996. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315-1321.
64. Chiu BC, Weisenburger DD, Cantor KP, et al. 2002. Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men. Ann Epidemiol 12:309-315.
65. Chow EJ, Holly EA. 2002a. Blood transfusions and non-Hodgkin's lymphoma. Epidemiol Rev 24:269-279.
66. Chow EJ, Holly EA. 2002b. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: A population-based study. Am J Epidemiol 155:725-731.
67. Cibere J, Sibley J, Haga M. 2001. Systemic lupus erythematosus and the risk of malignancy. Lupus 10:394-400.
68. Clarke CA, Glaser SL. 2001. Epidemiologic trends in HIV-associated lymphomas. Curr Opin Oncol 13:354-359.
69. Cleghorn FR, Manns A, Falk R, et al. 1995. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 87:1009-1014.
70. Cocco P, Broccia G, Aru G, et al. 2003. Nitrate in community water supplies and incidence of non-Hodgkin's lymphoma in Sardinia, Italy. J Epidemiol Community Health 57:510-511.
71. Cohen K, Scadden DT. 2001. Non-Hodgkin's lymphoma: pathogenesis, clinical presentation, and treatment, Cancer Treat Res 104:201-230.
72. Cohn P, Klotz J, Bove F, Berkowitz M, Fagliano J. 1994. Drinking water contamination and the incidence of leukemia and non-Hodgkin's lymphoma. Environ Health Perspect 102:556-561.
73. Corrao G, Corazza GR, Bagnardi V, et al. 2001. Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 358:356-361.
74. Correa A, Jackson L, Mohan A, Perry H, Helzlsouer K. 2000. Use of hair dyes, hematopoietic neoplasms, and lymphomas: A literature review. II. Lymphomas and multiple myeloma. Cancer Invest 18:467-479.
75. Cote TR, Biggar RJ, Rosenberg PS, et al. 1997. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73:645-650.
76. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. 1996. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88:675-679.
77. Council of State and Territorial Epidemiologists. 1985. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. MMWR Morb Mortal Wkly Rep 34:373-375.
78. Council of State and Territorial Epidemiologists. 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36 Suppl 1:1S-15S.
79. Cucuianu A, Patiu M, Duma M, et al. 1999. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 107:353-356.
80. Cuttner J, Werther JL, McGlynn P, et al. 2001. Seroprevalence of Helicobacter pylori infection in patients with lymphoma. Leuk Lymphoma 40:591-597.
81. Daibata M, Nemoto Y, Kamioka M, Imai S, Taguchi H. 2003. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br J Haematol 121:190-191.
82. dal Maso L, Franceschi S. 2003. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 4:110-119.
83. Dalla-Favera R, Gaidano G. 2001. Molecular biology of lymphomas. In: DeVita VTJ, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams, and Wilkins, pp. 2215-2234.
84. Damber L, Larsson LG, Johansson L, Norin T. 1995. A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. I. Epidemiological analyses. Acta Oncol 34:713-719.
85. David H, Mendoza S, Konishi T, Miller CW. 2001. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 162:57-64.
86. De Roos AJ, Zahm SH, Cantor KP, et al. 2003. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup Environ Med 60:E11.
87. De Rosa G, Gobbo ML, De Renzo A, et al. 1997. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 55:77-82.
88. de Sanjose S, Shah KV, Domingo-Domenech E, et al. 2003. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 104:522-524.
89. Devesa SS, Fears T. 1992. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 52:5432s-5440s.
90. Diamandopoulos GT. 1972. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176:173-175.
91. Dickinson HO, Parker L. 2002. Leukaemia and non-Hodgkin's lymphoma in children of male Sellafield radiation workers. Int J Cancer 99:437-444.
92. Doglioni C, Wotherspoon AC, Moschini A, De Boni M, Isaacson PG. 1992. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834-835.
93. Dong C, Hemminki K. 2001a. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92:144-150.
94. Dong C, Hemminki K. 2001b. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: A search for common mechanisms. Br J Cancer 85:997-1005.
95. Doody MM, Linet MS, Glass AG, et al. 1996. Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medication. Epidemiology 7:131-139.
96. Doody MM, Linet MS, Glass AG, et al. 1992. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 3:449-456.
97. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM, Kaldo JM. 2002. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 29:388-395.
98. Egan KM, Sosman JA, Blot WJ. 2005. Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst Feb 2;97(3):161-163.
99. Eheman CR, Tolbert PE, Coates RJ, Devine O, Eley JW. 2000. Case-control assessment of the association between non-Hodgkin's lymphoma and occupational radiation with doses assessed using a job exposure matrix. Am J Ind Med 38:19-27.
100. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. 2001. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 27:750-756.
101. Elenitoba-Johnson KS, Jaffe ES. 1997. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 14:35-47.
102. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. 2002. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 94:1204-1210.
103. Engels EA, Chatterjee N, Cerhan JR, et al. 2003a. Hepatitis C virus infection and non-Hodgkin lymphoma: Results of the NCI-SEER multi-center case-control study. Int J Cancer 111:76-80.
104. Engels EA, Katki HA, Nielsen NM, et al. 2003b. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 95:532-539.
105. Engels EA, Rodman LH, Frisch M, Goedert JJ, Biggar RJ. 2003c. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer 106:283-287.
106. Engels EA, Viscidi RP, Galloway DA, et al. 2004. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. JNCI 6(18):1368-1374.
107. Engels EA, Chen J, Hartge P, et al. 2005. Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma. Cancer Epi Bio Prev Feb;14(2):521-524.
108. Eriksson NE, Holmen A, Hogstedt B, Mikoczy Z, Hagmar L. 1995. A prospective study of cancer incidence in a cohort examined for allergy. Allergy 50:718-722.
109. Evans LS, Hancock BW. 2003. Non-Hodgkin lymphoma. Lancet 362:139-146.
110. Ferri C, Caracciolo F, Zignego AL, et al. 1994. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 88:392-394.
111. Figgs LW, Dosemeci M, Blair A. 1995. United States non-Hodgkin's lymphoma surveillance by occupation 1984-1989: A twenty-four state death certificate study. Am J Ind Med 27:817-835.
112. Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS. 1994. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 5:91-112.
113. Filipovich AH, Mathur A, Kamat D, Shapiro RS. 1992. Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Res 52:5465s-5467s.
114. Fisher SG, Weber L, Carbone M. 1999. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 19:2173-2180.
115. Floret N, Mauny F, Challier B, Arveux P, Cahn JY, Viel JF. 2003. Dioxin emissions from a solid waste incinerator and risk of non-Hodgkin lymphoma. Epidemiology 14:392-398.
116. Freedman DM, Cantor KP, Ward MH, Helzlsouer KJ. 2000. A case-control study of nitrate in drinking water and non-Hodgkin's lymphoma in Minnesota. Arch Environ Health 55:326-329.
117. Freedman DM, Zahm SH, Dosemeci M. 1997. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 314:1451-1455.
118. Fritschi L, Johnson KC, Kliewer EV, Fry R. 2002. Animal-related occupations and the risk of leukemia, myeloma, and non-Hodgkin's lymphoma in Canada. Cancer Causes Control 13:563-571.
119. Fritschi L, Siemiatycki J. 1996. Lymphoma, myeloma and occupation: results of a casecontrol study. Int J Cancer 67:498-503.
120. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. 2000. International Classification of Diseases for Oncology. Geneva: World Health Organization.
121. Gaidano G, Carbone A, Dalla-Favera R. 1998. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. J Natl Cancer Inst Monogr 95-100.
122. Gaidano G, Dalla-Favera R. 1992. Biologic aspects of human immunodeficiency virus-related lymphoma. Curr Opin Oncol 4:900-906.
123. Gaidano G, Pastore C, Gloghini A, et al. 1996. AIDS-related non-Hodgkin's lymphomas: Molecular genetics, viral infection and cytokine deregulation. Acta Haematol 95:193-198.
124. Gallo RC, Poiesz BJ, Ruscetti FW. 1981. Regulation of human T-cell proliferation: T-cell growth factor and isolation of a new class of type-C retroviruses from human T-cells. Haematol Blood Transfus 26:502-514.
125. Garabedian MJ, Hoppin JA, Tolbert PE, Herrick RF, Brann EA. 1999. Occupational chlorophenol exposure and non-Hodgkin's lymphoma. J Occup Environ Med 41:267-272.
126. Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD. 1990. Results of casecontrol study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ 300:423-429.
127. Gazdar AF, Butel JS, Carbone M. 2002. SV40 and human tumours: Myth, association or causality? Nat Rev Cancer 2:957-964.
128. Gerard L, Galicier L, Maillard A, et al. 2002. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: Persistent occurrence but improved survival. J Acquir Immune Defic Syndr 30:478-484.
129. Germanidis G, Haioun C, Dhumeaux D, Reyes F, Pawlotsky JM. 1999. Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma. Hepatology 30:822-823.
130. Gilbert ES, Omohundro E, Buchanan JA, Holter NA. 1993. Mortality of workers at the Hanford site: 1945-1986. Health Phys 64:577-590.
131. Goedert JJ, Cote TR, Virgo P, et al. 1998. Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839.
132. Goggins WB, Finkelstein DM, Tsao H. 2001. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 91:874-880.
133. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
134. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. 2003. Risk of malignancy in patients with celiac disease. Am J Med 115:191-195.
135. Gridley G, Klippel JH, Hoover RN, Fraumeni JF, Jr. 1994. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120:35-39.
136. Gridley G, McLaughlin JK, Ekbom A, et al. 1993. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307-311.
137. Grodstein F, Hennekens CH, Colditz GA, Hunter DJ, Stampfer MJ. 1994. A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 86:1466-1470.
138. Groves FD, Linet MS, Travis LB, Devesa SS. 2000. Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92:1240-1251.
139. Grulich AE, Wan X, Law MG, et al. 2000. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 14:133-140.
140. Gulis G, Czompolyova M, Cerhan JR. 2002. An ecologic study of nitrate in municipal drinking water and cancer incidence in Trnava District, Slovakia. Environ Res 88:182-187.
141. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. 2001. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12:552-557.
142. Hakulinen T, Isomaki H, Knekt P. 1985. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 78:29-32.
143. Hansen J, Raaschou-Nielsen O, Christensen JM, et al. 2001. Cancer incidence among Danish workers exposed to trichloroethylene. J Occup Environ Med 43:133-139.
144. Hardell L, Eriksson M. 1999. A case-control study of non-Hodgkin lymphoma and exposure to pesticides. Cancer 85:1353-1360.
145. Hardell L, Eriksson M, Degerman A. 1994. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma. Cancer Res 54:2386-2389.
146. Hardell L, Eriksson M, Lenner P, Lundgren E. 1981. Maligant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: A case-control study. Br J Cancer 43:169-176.
147. Hardell L, Eriksson M, Lindstrom G, et al. 2001a. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin's lymphoma. Leuk Lymphoma 42:619-629.
148. Hardell L, Eriksson M, Nordstrom M. 2002. Exposure to pesticides as risk factor for non-Hodgkin's lymphoma and hairy cell leukemia: Pooled analysis of two Swedish case-control studies. Leuk Lymphoma 43:1043-1049.
149. Hardell L, Liljegren G, Lindstrom G, et al. 1996a. Increased concentrations of chlordane in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 9:1139-1142.
150. Hardell L, Lindstrom G, Van Bavel B, et al. 2001b. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma. Environ Res 87:99-107.
151. Hardell L, Van Bavel B, Lindstrom G, et al. 1996b. Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 9:603-608.
152. Harris NL, Jaffe ES, Diebold J, et al. 1999. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17:3835-3849.
153. Harris NL, Jaffe ES, Stein H, et al. 1994. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392.
154. Harris NL, Stein H, Coupland SE, et al. 2001. New approaches to lymphoma diagnosis. Hematology (Am Soc Hematol Educ Program):194-220.
155. Hartge P, Devesa SS. 1992. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 52:5566s-5569s.
156. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF, Jr. 1996. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88:298-300.
157. Hauke RJ, Armitage JO. 2000. A new approach to non-Hodgkin's lymphoma. Intern Med 39:197-208.
158. Hausfater P, Rosenthal E, Cacoub P. 2000. Lymphoproliferative diseases and hepatitis C virus infection. Ann Med Interne (Paris) 151:53-57.
159. Hemminki K, Jiang Y, Steineck G. 2003. Skin cancer and non-Hodgkin's lymphoma as second malignancies markers of impaired immune function? Eur J Cancer 39:223-229.
160. Hermine O, Lefrere F, Bronowicki JP, et al. 2002. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89-94.
161. Herndier BG, Kaplan LD, McGrath MS. 1994. Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049.
162. Herrinton LJ. 1998. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 20:187-203.
163. Herrinton LJ, Friedman GD. 1998. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 7:25-28.
164. Hoar SK, Blair A, Holmes FF, et al. 1986. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. J Am Med Assn 256:1141-1147.
165. Hoar SK, Pell S. 1981. A retrospective cohort study of mortality and cancer incidence among chemist. J Occup Med 23:485-494.
166. Holly EA, Bracci PM. 2003. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 158:316-327.
167. Holly EA, Gautam M, Bracci PM. 2002. Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann Epidemiol 12:419-425.
168. Holly EA, Lele C. 1997. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: Allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 15:211-222.
169. Holly EA, Lele C, Bracci PM. 1998. Hair-color products and risk for non-Hodgkin's lymphoma: A population-based study in the San Francisco bay area. Am J Public Health 88:1767-1773.
170. Holly EA, Lele C, Bracci PM, McGrath MS. 1999. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375-389.
171. Hoover R, Fraumeni JFJ. 1973. Risk of cancer in renal-transplant recipients. Lancet 2:55-57.
172. Hsu JL, Glaser SL. 2000. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34:27-53.
173. Hughes AM, Armstrong BK, Vajdic CM, et al. 2004. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer Dec 10;112(5):865-871.
174. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. 1995. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low-and high-grade types. J Pathol 175:263-271.
175. Inskip PD, Kleinerman RA, Stovall M, et al. 1993. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res 135:108-124.
176. Immunization Safety Review Institute of Medicine. 2002. SV40 contamination of polio vaccine and cancer. Washington, DC: The National Academies Press.
177. International Agency for Research on Cancer. 1995. IARC Monographs on the evaluation of carcinogenic risks to humans: Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon, France: International Agency for Research on Cancer.
178. International Agency for Research on Cancer. 1997. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 70:1-492.
179. International Collaboration on HIV and Cancer. 2000. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823-1830.
180. Jablon S, Miller RW. 1978. Army technologists: 29-year follow up for cause of death. Radiology 126:677-679.
181. Jaffe E, Harris NL, Stein H, Vardiman J. 2001. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC.
182. Jemal A, Siegel R, Ward EM, Thun MJ. 2006. Cancer Facts & Figures 2006. CA Cancer J Clin 56:1-52.
183. Johnson ES, Dalmas D, Noss J, Matanoski GM. 1995. Cancer mortality among workers in abattoirs and meatpacking plants: An update. Am J Ind Med 27:389-403.
184. Johnson ES, Shorter C, Rider B, Jiles R. 1997. Mortality from cancer and other diseases in poultry slaughtering/processing plants. Int J Epidemiol 26:1142-1150.
185. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW. 1999. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr 21 Suppl 1:S11-S17.
186. Kadan-Lottick NS, Skluzacek MC, Gurney JG. 2002. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95:193-202.
187. Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. 1999. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 26:1676-1680.
188. Karcher DS, Alkan S. 1997. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: A unique B-cell neoplasm. Hum Pathol 28:801-808.
189. Kassan SS, Thomas TL, Moutsopoulos HM, et al. 1978. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888-892.
190. Kauppi M, Hakala M. 1994. Prevalence of cervical spine subluxations and dislocations in a community-based rheumatoid arthritis population. Scand J Rheumatol 23:133-136.
191. Kauppi M, Pukkala E, Isomaki H. 1997. Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 8:201-204.
192. Kauppinen T, Pukkala E, Saalo A, Sasco AJ. 2003. Exposure to chemical carcinogens and risk of cancer among Finnish laboratory workers. Am J Ind Med 44:343-350.
193. Kendall GM, Muirhead CR, MacGibbon BH, et al. 1992. Mortality and occupational exposure to radiation: First analysis of the National Registry for Radiation Workers. BMJ 304:220-225.
194. King PD, Wilkes JD, Diaz-Arias AA. 1998. Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol 20:107-110.
195. Kinlen LJ, Clarke K, Balkwill A. 1993. Paternal preconceptional radiation exposure in the nuclear industry and leukaemia and non-Hodgkin's lymphoma in young people in Scotland. BMJ 306:1153-1158.
196. Kinlen LJ, Dickson M, Stiller CA. 1995. Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with a comparison with Sellafield nuclear site. BMJ 310:763-768.
197. Kirk O, Pedersen C, Cozzi-Lepri A, et al. 2001. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406-3412.
198. Knowles DM. 1996. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 10:1081-1109.
199. Knowles DM. 1999. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12:200-217.
200. Knowles DM, Cesarman E. 1997. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases. Ann Oncol 8 Suppl 2:123-129.
201. Kogevinas M, Kauppinen T, Winkelmann R, et al. 1995. Soft tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: Two nested case-control studies. Epidemiology 6:396-402.
202. Kristensen P, Andersen A, Irgens LM, Laake P, Bye AS. 1996. Incidence and risk factors of cancer among men and women in Norwegian agriculture. Scand J Work Environ Health 22:14-26.
203. Lamba AB, Ward MH, Weeks JL, Dosemeci M. 2001. Cancer mortality patterns among hairdressers and barbers in 24 US states, 1984 to 1995. J Occup Environ Med 43:250-258.
204. Lan Q, Zhang L, Li G, et al. 2004. Hematotoxicity in workers exposed to low levels of benzene. Science Dec 3;306(5702):1774-1776.
205. Law GR, Parslow RC, Roman E. 2003. Childhood cancer and population mixing. Am J Epidemiol 158:328-336.
206. Leandro MJ, Isenberg DA. 2001. Rheumatic diseases and malignancy-is there an association? Scand J Rheumatol 30:185-188.
207. Lehtinen T, Lumio J, Dillner J, et al. 1993. Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies-a prospective study. Cancer Causes Control 4:187-193.
208. Levi F, Randimbison L, Te VC, La Vecchia C. 1996. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 74:1847-1850.
209. Levine AM. 1992. Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20.
210. Levine AM. 1994. Lymphoma complicating immunodeficiency disorders. Ann Oncol 5 Suppl 2:29-35.
211. Linet MS, Pottern LM. 1992. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res 52:5468s-5473s.
212. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. 2001. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39-40.
213. Liu S, Semenciw R, Mao Y. 2003. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: Age-period-cohort analysis. Hematol Oncol 21:57-66.
214. Luppi M, Ferrari MG, Torelli G. 1998. Hepatitis C virus genotype distribution in B-cell non-Hodgkin lymphoma. Ann Intern Med 128:602.
215. Luppi P. 2003. How immune mechanisms are affected by pregnancy. Vaccine 21:3352-3357.
216. MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. 2003. Association between simian virus 40 DNA and lymphoma in the United kingdom. J Natl Cancer Inst 95:1001-1003.
217. Malkin D. 2002. Simian virus 40 and non-Hodgkin lymphoma. Lancet 359:812-813.
218. Manns A, Cleghorn FR, Falk RT, et al. 1993. Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study Group. Lancet 342:1447-1450.
219. Mao Y, Hu J, Ugnat AM, White K. 2000. Non-Hodgkin's lymphoma and occupational exposure to chemicals in Canada. Canadian Cancer Registries Epidemiology Research Group. Ann Oncol 11 Suppl 1:69-73.
220. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. 2002. Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France. Blood 99:3909-3915.
221. Masala G, Di Lollo S, Picoco C, et al. 1996. Incidence rates of leukemias, lymphomas and myelomas in Italy: Geographic distribution and NHL histotypes. Int J Cancer 68:156-159.
222. Mazzaro C, Zagonel V, Monfardini S, et al. 1996. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 94:544-550.
223. McDuffie HH, Pahwa P, McLaughlin JR, et al. 2001. Non-Hodgkin's lymphoma and specific pesticide exposures in men: Cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 10:1155-1163.
224. McDuffie HH, Pahwa P, Spinelli JJ, et al. 2002. Canadian male farm residents, pesticide safety handling practices, exposure to animals and non-Hodgkin's lymphoma (NHL). Am J Ind Med Suppl 2:54-61.
225. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF, Jr. 1995. Smoking and cancer mortality among U.S. veterans: A 26-year follow-up. Int J Cancer 60:190-193.
226. McLaughlin JR, King WD, Anderson TW, Clarke EA, Ashmore JP. 1993. Paternal radiation exposure and leukaemia in offspring: The Ontario case-control study. BMJ 307:959-966.
227. McMichael AJ, Giles GG. 1996. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 73:945-950.
228. McNally RJ, Roman E, Cartwright RA. 1999. Leukemias and lymphomas: time trends in the UK, 1984-93. Cancer Causes Control 10:35-42.
229. Medina KL, Strasser A, Kincade PW. 2000. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95:2059-2067.
230. Mele A, Pulsoni A, Bianco E, et al. 2003. Hepatitis C virus and B-cell non-Hodgkin lymphomas: An Italian multicenter case-control study. Blood 102:996-999.
231. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. 1997. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40:761-768.
232. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. 1996. Rheumatoid arthritis and cancer risk. Eur J Cancer 32A: 1753-1757.
233. Mellors RC. 1966. Autoimmune and immunoproliferative diseases of NZB/BI mice and hybrids. Int Rev Exp Pathol 5:217-252.
234. Memon A, Doll R. 1994. A search for unknown blood-borne oncogenic viruses. Int J Cancer 58:366-368.
235. Metayer C, Johnson ES, Rice JC. 1998. Nested case-control study of tumors of the hemopoietic and lymphatic systems among workers in the meat industry. Am J Epidemiol 147:727-738.
236. Metayer C, Lynch CF, Clarke EA, et al. 2000. Second cancers among longterm survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443.
237. Miligi L, Seniori CA, Crosignani P, et al. 1999. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 36:60-69.
238. Miller AB, Barclay TH, Choi NW, et al. 1980. A study of cancer, parity and age at first pregnancy. J Chronic Dis 33:595-605.
239. Mills PK, Beeson WL, Fraser GE, Phillips RL. 1992. Allergy and cancer: Organ site-specific results from the Adventist Health Study. Am J Epidemiol 136:287-295.
240. Minor P, Pipkin P, Jarzebek Z, Knowles W. 2003. Studies of neutralising antibodies to SV40 in human sera. J Med Virol 70:490-495.
241. Misra RR, Pinsky PF, Srivastava S. 2000. Prognostic factors for hematologic cancers. Hematol Oncol Clin North Am 14:907-924.
242. Mohan AK, Hauptmann M, Freedman DM, et al. 2003. Cancer and other causes of mortality among radiologic technologists in the United States. Int J Cancer 103:259-267.
243. Moller P, Wallin H, Holst E, Knudsen LE. 2002. Sunlight-induced DNA damage in human mononuclear cells. FASEB J 16:45-53.
244. Morgan RW, Kelsh MA, Zhao K, Heringer S. 1998. Mortality of aerospace workers exposed to trichloroethylene. Epidemiology 9:424-431.
245. Morra E. 1999. The biological markers of non-Hodgkin's lymphomas: Their role in diagnosis, prognostic assessment and therapeutic strategy. Int J Biol Markers 14:149-153.
246. Morton LM, Holford TR, Leaderer B, et al. 2003. Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control 14:687-694.
247. Morton LM, Wang SS, Devesa SS, et al. 2005a. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. [Epub ahead of print].
248. Morton LM, Hartge P, Holford T, et al. 2005b. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph consortium. Cancer Epi Bio Prev 14:925-933.
249. Morton LM, Zheng T, Holford T, et al. 2005c. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph consortium. Lancet Oncol Jul;6(7):469-476.
250. Mortreux F, Gabet AS, Wattel E. 2003. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 17:26-38.
251. Mueller N. 1999. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Synd 21:S5-S10.
252. Mueller N, Mohar A, Evans A, et al. 1991. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 49:387-393.
253. Mueller NE, Blattner WA. 1997. Retroviruses-Human T-cell lymphitropic virus. In: Evans AS, Kaslow RA, eds. Viral Infections of humans: Epidemiology and control. New York: Plenum Publishing Corporation, pp. 785-813.
254. Nador RG, Cesarman E, Chadburn A, et al. 1996. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88:645-656.
255. Nagy N, Mattsson K, Maeda A, Liu A, Szekely L, Klein E. 2002. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. Immunol Lett 82:141-147.
256. Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. 1997. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 79:3-11.
257. Nanni O, Amadori D, Lugaresi C, et al. 1996. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: A population case-control study based on a priori exposure matrices. Occup Environ Med 53:652-657.
258. National Cancer Institute. 2003. Surveillance research program. SEER*Stat, 2003 version 5.0.19.
259. National Cancer Institute (NCI). 1982. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112-2135.
260. Nelson RA, Levine AM, Bernstein L. 2001. Reproductive factors and risk of intermediate-or high-grade B-Cell non-Hodgkin's lymphoma in women. J Clin Oncol 19:1381-1387.
261. Nelson RA, Levine AM, Marks G, Bernstein L. 1997. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer 76:1532-1537.
262. Neubauer A, Thiede C, Morgner A, et al. 1997. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89:1350-1355.
263. Newton R, Ferlay J, Beral V, Devesa SS. 1997. The epidemiology of non-Hodgkin's lymphoma: Comparison of nodal and extra-nodal sites. Int J Cancer 72:923-930.
264. Niedobitek G, Meru N, Delecluse HJ. 2001. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 82:149-170.
265. Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. 2002. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 155:1054-1059.
266. Non-Hodgkin's Lymphoma Classification Project. 1997. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89:3909-3918.
267. O'Connor SR, Farmer PB, Lauder I. 1999. Benzene and non-Hodgkin's lymphoma. J Pathol 189:448-453.
268. Oksenhendler E, Boulanger E, Galicier L, et al. 2002. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331-2336.
269. Ollier W. 2000. Rheumatoid arthritis and Epstein-Barr virus: A case of living with the enemy? Ann Rheum Dis 59:497-499.
270. Olsen JH, Hahnemann JM, Borresen-Dale AL, et al. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 93:121-127.
271. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. 2002a. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the lowa Women's Health Study. Cancer 94:1612-1618.
272. Olson JE, Janney CA, Rao RD, et al. 2002b. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and end results analysis. Cancer 95:1504-1510.
273. Olsson H, Olsson ML, Ranstam J. 1990. Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 37:185-190.
274. Opelz G, Henderson R. 1993. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514-1516.
275. Opelz G, Schwarz V, Henderson R, Kneifel G, Ruhenstroth A. 1994. Non-Hodgkin's lymphoma after kidney or heart transplantation: Frequency of occurrence during the first posttransplant year. Transpl Int 7 Suppl 1:S353-S356.
276. Parker AS, Cerhan JR, Dick F, et al. 2000. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 37:341-349.
277. Parkin DM, Whelan S, Ferlay J, Teppo L, Thomas D. 2003. Cancer incidence in five continents, Vol. VIII. Lyon: IARC Press.
278. Parsonnet J. 1998. Helicobacter pylori. Infect Dis Clin North Am 12:185-197.
279. Parsonnet J, Hansen S, Rodriguez L, et al. 1994. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271.
280. Penn I. 2000. Some problems with posttransplant lymphoproliferative disease. Transplantation 69:705-706.
281. Penn I, Hammond W, Brettschneider L, Starzl TE. 1969. Malignant lymphomas in transplantation patients. Transplant Proc 1:106-112.
282. Percy C, Van Holten V, Muir C. 1990. International Classification of Diseases for Oncology. Geneva: World Health Organization.
283. Persson B, Fredrikson M. 1999. Some risk factors for non-Hodgkin's lymphoma. Int J Occup Med Environ Health 12:135-142.
284. Pettersson T, Rosenlof K, Friman C, Mickos A, Teppo AM, Fyhrquist F. 1993. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol 22:188-193.
285. Pioltelli P, Gargantini L, Cassi E, et al. 2000. Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Hematol 64:95-100.
286. Poiesz BJ, Papsidero LD, Ehrlich G, et al. 2001. Prevalence of HTLV-Iassociated T-cell lymphoma. Am J Hematol 66:32-38.
287. Pottern LM, Linet M, Blair A, et al. 1991. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res 15:305-314.
288. Preston DL, Kusumi S, Tomonaga M, et al. 1994. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 137:S68-S97.
289. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. 2001. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98:3745-3749.
290. Raaschou-Nielsen O, Hertel O, Thomsen BL, Olsen JH. 2001. Air pollution from traffic at the residence of children with cancer. Am J Epidemiol 153:433-443.
291. Rao PH, Houldsworth J, Dyomina K, et al. 1998. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92:234-240.
292. Raphael M, Borisch B, Jaffe E. 2001. Lymphomas associated with infection by the human immune deficiency virus (HIV). In: Jaffe E, Harris NL, Stein H, Vardiman J, eds. Pathology and Genetics of Tumours of Haematopioetic and Lymphoid Tissues. Lyon, France: IARC Press, pp. 260-263.
293. Rappaport H. 1966. Tumors of the hematopoietic system. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology.
294. Ridolfo AL, Santambrogio S, Mainini F, et al. 1996. High frequency of non-Hodgkin's lymphoma in patients with HIV-associated Kaposi's sarcoma. AIDS 10:181-185.
295. Ries LA, Eisner MP, Kosary CL, et al. 2003. SEER Cancer Statistics Review 1975-2000. SEER Cancer Statistics Review 1975-2000.
296. Rizzo P, Carbone M, Fisher SG, et al. 1999. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 116:470S-473S.
297. Ron E, Boice JD, Jr., Hamburger S, Stovall M. 1994. Mortality following radiation treatment for infertility of hormonal origin or amenorrhoea. Int J Epidemiol 23:1165-1173.
298. Ron E, Modan B, Boice JD, Jr. 1988. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol 127:713-725.
299. Rothman N, Cantor KP, Blair A, et al. 1997. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 350:240-244.
300. Rothman N, Skibola C, Wang SS, et al. 2006. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27-38.
301. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. 2001. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 48:297-303.
302. Savitz DA, Andrews KW. 1997. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med 31:287-295.
303. Savitz DA, Wachtel H, Barnes FA, John EM, Tvrdik JG. 1988. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol 128:21-38.
304. Scherr PA, Mueller NE. 1996. Non-Hodgkin's lymphoma. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention 2nd edition. New York: Oxford University Press, pp. 920-945.
305. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. 1998. Risk factors for primary central nervous system lymphoma: A case-control study. Cancer 82:975-982.
306. Schroeder JC, Olshan AF, Dent RB, et al. 2002. A case-control study of tobacco use and other non-occupational risk factors for t(14; 18) subtypes of non-Hodgkin's lymphoma (United States). Cancer Causes Control 13:159-168.
307. Schroeder JC, Savitz DA. 1997. Lymphoma and multiple myeloma mortality in relation to magnetic field exposure among electric utility workers. Am J Ind Med 32:392-402.
308. Schulz TF. 2000. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis. J Antimicrob Chemother 45 Suppl T3:15-27.
309. SEER*STAT. 2003. NCI software package to access SEER public-use file: 1973-2000. Available at:
310. Settimi L, Comba P, Bosia S, et al. 2001. Cancer risk among male farmers: A multi-site case-control study. Int J Occup Med Environ Health 14:339-347.
311. Shah KV. 2000. Does SV40 infection contribute to the development of human cancers? Rev Med Virol 10:31-43.
312. Shimizu Y, Kato H, Schull WJ. 1990. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res 121:120-141.
313. Shiramizu B, Herndier BG, McGrath MS. 1994. Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Res 54:2069-2072.
314. Shivapurkar N, Harada K, Reddy J, et al. 2002. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 359:851-852.
315. Siegel R, Gartenhaus R, Kuzel T. 2001. HTLV-I associated leukemia/lymphoma: Epidemiology, biology, and treatment. Cancer Treat Res 104:75-88.
316. Silvestri F, Barillari G, Fanin R, et al. 1997. The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma. Leukemia 11:2157-2161.
317. Silvestri F, Pipan C, Barillari G, et al. 1996. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87:4296-4301.
318. Skibola CF, Bracci PM, Paynter RA, et al. 2005a. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-Omethyltransferase genes and non-Hodgkin lymphoma risk. Cancer Epidemiol Biomarkers Prev 14:2391-2401.
319. Skibola CF, Forrest MS, Coppede F, et al. 2005b. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 105:906-907.
320. Skibola CF, Holly EA, Forrest MS, et al. 2004. Body mass index, leptin and leptin receptor polymorphisms and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. Cancer Epi Bio Prev 13:779-786.
321. Skibola DR, Smith MT, Bracci PM, et al. 2005. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. 2005. Cancer Epidemiol Biomarkers Prev 14:1251-1256.
322. Smedby KE, Hjalgrim H, Melbye M, et al. 2005. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst Feb 2;97:199-209.
323. Smets F, Latinne D, Bazin H, et al. 2002. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73:1603-1610.
324. Stagnaro E, Ramazzotti V, Crosignani P, et al. 2001. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 12:325-334.
325. Staudt LM. 2002. Gene expression profiling of lymphoid malignancies. Annu Rev Med 53:303-318.
326. Staudt LM. 2003. Molecular diagnosis of the hematologic cancers. N Engl J Med 348:1777-1785.
327. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Jr., Goedert JJ. 1998. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279:292-295.
328. Sullivan CS, Pipas JM. 2002. T antigens of simian virus 40: Molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66:179-202.
329. Svensson BG, Mikoczy Z, Stromberg U, Hagmar L. 1995. Mortality and cancer incidence among Swedish fishermen with a high dietary intake of persistent organochlorine compounds. Scand J Work Environ Health 21:106-115.
330. Sweet BH, Hilleman MR. 1960. The vacuolating virus SV40. Proc Soc Exp Biol Med 1960:1-12.
331. Swerdlow AJ, Higgins CD, Hunt BJ, et al. 2000. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus. Transplantation 69:897-904.
332. Swinnen LJ. 2000. Transplantation-related lymphoproliferative disorder: A model for human immunodeficiency virus-related lymphomas. Semin Oncol 27:402-408.
333. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. 1990. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723-1728.
334. Tam HK, Zhang ZF, Jacobson LP, et al. 2002. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916-922.
335. Tavani A, Gallus S, La Vecchia C, Franceschi S. 2001. Alcohol drinking and risk of non-Hodgkin's lymphoma. Eur J Clin Nutr 55:824-826.
336. Tavani A, Negri E, Franceschi S, Serraino D, La Vecchia C. 1994a. Smoking habits and non-Hodgkin's lymphoma: A case-control study in northern Italy. Prev Med 23:447-452.
337. Tavani A, Negri E, Franceschi S, Talamini R, La Vecchia C. 1994b. Coffee consumption and risk of non-Hodgkin's lymphoma. Eur J Cancer Prev 3:351-356.
338. Tavani A, Pregnolato A, La Vecchia C, Franceschi S. 1997. A case-control study of reproductive factors and risk of lymphomas and myelomas. Leuk Res 21:885-888.
339. Tiirikainen MI, Mullaney BP, Holly EA, Pallavicini MG, Jensen RH. 2001. DNA copy number alterations in HIV-positive and HIV-negative patients with diffuse large-cell lymphomas. J Acquir Immune Defic Syndr 27:272-276.
340. Ullrich A, Fischbach W, Blettner M. 2002. Incidence of gastric B-cell lymphomas: A population-based study in Germany. Ann Oncol 13:1120-1127.
341. Urquhart JD, Black RJ, Muirhead MJ, et al. 1991. Case-control study of leukaemia and non-Hodgkin's lymphoma in children in Caithness near the Dounreay nuclear installation. BMJ 302:687-692.
342. Valesini G, Priori R, Bavoillot D, et al. 1997. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome. J Rheumatol 24:2376-2380.
343. Vallisa D, Berte R, Rocca A, et al. 1999. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 106:556-560.
344. Van Wijngaarden E, Savitz DA. 2001. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 43:548-553.
345. Vega F, Medeiros LJ. 2003. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med 127:1148-1160.
346. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS. 2003. Simian virus 40 in human cancers. Am J Med 114:675-684.
347. Vilchez RA, Madden CR, Kozinetz CA, et al. 2002. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359:817-823.
348. Vineis P, Crosignani P, Sacerdote C, et al. 1999. Hematopoietic cancer and peptic ulcer: A multicenter case-control study. Carcinogenesis 20:1459-1463.
349. Vineis P, Crosignani P, Sacerdote C, et al. 2000. Haematopoietic cancer and medical history: A multicentre case control study. J Epidemiol Community Health 54:431-436.
350. Waddell BL, Zahm SH, Baris D, et al. 2001. Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States). Cancer Causes Control 12:509-517.
351. Wang JX, Zhang LA, Li BX, et al. 2002. Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995. Health Phys 82:455-466.
352. Ward MH, Mark SD, Cantor KP, Weisenburger DD, Correa-Villasenor A, Zahm SH. 1996. Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology 7:465-471.
353. Ward MH, Zahm SH, Weisenburger DD, et al. 1994. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control 5:422-432.
354. Waterhouse D, Carman WJ, Schottenfeld D, Gridley G, McLean S. 1996. Cancer incidence in the rural community of Tecumseh, Michigan: A pattern of increased lymphopoietic neoplasms. Cancer 77:763-770.
355. Weiss HA, Darby SC, Doll R. 1994. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 59:327-338.
356. Weng WK, Levy S. 2003. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 44:1113-1120.
357. Weyer PJ, Cerhan JR, Kross BC, et al. 2001. Municipal drinking water nitrate level and cancer risk in older women: The lowa Women's Health Study. Epidemiology 12:327-338.
358. Wilks R, Hanchard B, Morgan O, et al. 1996. Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis. Int J Cancer 65:272-273.
359. Wingle DT, Semenciw RM, Wilkins K, et al. 1990. Mortality study of Canadian male farm operators: Non-Hodgkin's lymphoma mortality and agricultural practices in Saskatchewan. J Natl Cancer Inst 82:575-582.
360. Wolk A, Gridley G, Svensson M, et al. 2001. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13-21.
361. Wong O, Raabe GK. 2000. Non-Hodgkin's lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996. J Occup Environ Med 42:554-568.
362. Wotherspoon AC, Dogan A, Du MQ. 2002. Mucosa-associated lymphoid tissue lymphoma. Curr Opin Hematol 9:50-55.
363. Wotherspoon AC, Doglioni C, Diss TC, et al. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577.
364. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176.
365. Wundisch T, Kim TD, Thiede C, et al. 2003. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas. Ann Hematol 82:535-545.
366. Zahm SH. 1997. Mortality study of pesticide applicators and other employees of a lawn care service company. J Occup Environ Med 39:1055-1067.
367. Zahm SH, Hoffman-Goetz L, Dosemeci M, Cantor KP, Blair A. 1999. Occupational physical activity and non-Hodgkin's lymphoma. Med Sci Sports Exerc 31:566-571.
368. Zahm SH, Ward MH, Blair A. 1997a. Pesticides and cancer. Occup Med 12:269-289.
369. Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Blair A. 1990. A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology 1:349-356.
370. Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Blair A. 1992. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 82:990-997.
371. Zahm SH, Weisenburger DD, Holmes FF, Cantor KP, Blair A. 1997b. Tobacco and non-Hodgkin's lymphoma: Combined analysis of three case-control studies (United States). Cancer Causes Control 8:159-166.
372. Zhang S, Hunter DJ, Rosner BA, et al. 1999. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 91:1751-1758.
373. Zhang SM, Hunter DJ, Rosner BA, et al. 2000. Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev 9:477-485.
374. Zheng T, Zahm SH, Cantor KP, Weisenburger DD, Zhang Y, Blair A. 2001. Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma. J Occup Environ Med 43:641-649.
375. Zhu K, Levine RS, Brann EA, et al. 2001. Risk factors for non-Hodgkin's lymphoma according to family history of haematolymphoproliferative malignancies. Int J Epidemiol 30:818-824.
376. Zhu K, Levine RS, Gu Y, et al. 1998. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 9:77-82.
377. Ziegler JL, Beckstead JA, Volberding PA, et al. 1984. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565-570.
378. Ziegler JL, Drew WL, Miner RC, et al. 1982. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 2:631-633.
379. Zignego AL, Ferri C, Giannelli F, et al. 2002. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137:571-580.
380. Zignego AL, Ferri C, Giannini C, et al. 1997. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: Evidence for a pathogenetic role. Arch Virol 142:545-555.
381. Zucca E, Roggero E, Maggi-Solca N, et al. 2000. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 85:147-153.
382. Zuckerman E, Zuckerman T, Levine AM, et al. 1997. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 127:423-428.
383. Zuckerman E, Zuckerman T, Sahar D, et al. 2001. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 112:364-369.
384. zur Hausen H, Schulte-Holthausen H, Klein G, et al. 1970. EB V DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056-1058.